Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M W Schottstaedt

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Critical Care Medicine|September 1, 1981
Placidyl abuse: a dimorphic pictureM W Schottstaedt, M B Nicotra, M Rivera
The American Journal of Medicine|May 1, 1987
Kaposi's sarcoma in rheumatoid arthritisM W Schottstaedt, E R Hurd, M J Stone
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1996
Randomized double-blind prospective trial to evaluate the effects of sargramostim versus placebo in a moderate-dose fluorouracil, doxorubicin, and cyclophosphamide adjuvant chemotherapy program for stage II and III breast cancerS E Jones, M W Schottstaedt, L A Duncan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 1998
A phase II study of docetaxel in patients with paclitaxel-resistant metastatic breast cancerV Valero, S E Jones, D D Von Hoff, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Critical Care Medicine|September 1, 1981
Placidyl abuse: a dimorphic pictureM W Schottstaedt, M B Nicotra, M Rivera
The American Journal of Medicine|May 1, 1987
Kaposi's sarcoma in rheumatoid arthritisM W Schottstaedt, E R Hurd, M J Stone
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1996
Randomized double-blind prospective trial to evaluate the effects of sargramostim versus placebo in a moderate-dose fluorouracil, doxorubicin, and cyclophosphamide adjuvant chemotherapy program for stage II and III breast cancerS E Jones, M W Schottstaedt, L A Duncan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 1998
A phase II study of docetaxel in patients with paclitaxel-resistant metastatic breast cancerV Valero, S E Jones, D D Von Hoff, et al.
Pageof 1